No Data
No Data
December 20 [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 Cybozu <4776> 2144 yen (12/19) engages in the development, sales, and operation of groupware such as 'kintone'. The year-end Dividends forecast for the fiscal year ending December 2024 has been revised to 'undecided'. The previous estimate was 15 yen, and the one before that was 14 yen. It is being considered for an increase, and it is scheduled to be announced immediately after it is confirmed. Additionally, the performance forecast for the fiscal year ending December 2025 was announced. The operating profit is estimated to be 8.437 billion yen.
Attention is being paid to Cybozu and Nihon Litec, while Kadokawa and others are showing weakness.
In the U.S. stock market yesterday, on the 19th, the Dow Jones Industrial Average rose by $15.37 to 42,342.24, the Nasdaq Composite Index fell by 19.93 points to 19,372.77, and the Chicago Nikkei 225 Futures decreased by 60 yen compared to the Osaka daytime price, settling at 39,020 yen. The exchange rate was 1 dollar = 157.30-40 yen. Today in the Tokyo market, Cybozu <4776> announced that it is considering an increase in the year-end Dividends for the fiscal year ending in December 2024, and the operating profit for the fiscal year ending in December 2025 is projected to be 8.437 billion yen, which is expected to be double compared to the current fiscal year forecast.
JCR Pharmaceuticals Launches Phase III Trial of JR-142 in Japan
Stocks that moved the day before part 2: Osaka Chemical Industry, Liberta, Terra Drone, ETC.
Stock Name <Code> Closing Price on 17th ⇒ Change from Previous Day SHIFT <3697> 16,970 -705 JP Morgan Securities has downgraded its investment rating. Sakura Internet <3778> 4,260 -265 fell below the 4,500 yen level. Double Scope <6619> 266 -6 experienced a dominant trend of short-term investor sell-offs due to sluggish movements. Monex Group <8698> 1,016 -48 saw a dominant trend of sell-offs from short-term investors after falling below the 25-day moving average. JCR Pharma <4
List of cloud break stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud break stocks]
○ List of stocks that have broken through the clouds Market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Main Board <1332> Nissui 907 921.5 918.5 <1375> Yukiguni Maitake 1013 1030.25 1019.5 <1860> Toda Construction 9219 27.25 957 <1882> Toa Road 1291 1304 1340.5 <1893> Goyo Construction 6216 32.75 624 <196
December 4th [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 JCR Pharma <4552> 727 yen (12/3) Human growth hormone preparation is the main product. The company announced that the first dose was administered to the first subject in the phase 1/2 clinical trial targeting mucopolysaccharidosis type 3B (MPS3B) in Japan for the blood-brain barrier penetrating α-N-acetylglucosaminidase preparation (JR-446) it developed. MPS3B is being co-developed and marketed with Medipal Holdings <7459>.
No Data